Foley Represents TCGX as Investor in Tourmaline Bio, Concurrent with Merger with Talaris Therapeutics

Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement for Tourmaline Bio, concurrent with the company’s merger with Talaris Therapeutics. Additional investors included Acuta Capital Partners, Affinity Asset Advisors, Braidwell LP, Cowen Healthcare Investments, Deep Track Capital, Great Point Partners, LLC, KVP Capital, Logos Capital, Paradigm BioCapital, Qiming Venture […]

New Jersey Passes Comprehensive Privacy Law to Lead the 2024 Wave of State Privacy Laws

On January 16, 2024, New Jersey Governor Phil Murphy signed Senate Bill (SB) 332, establishing New Jersey’s consumer data privacy law, the New Jersey Data Privacy Act (NJDPA) which will be effective January 15, 2025. This legislation marks New Jersey as the first state to implement comprehensive privacy legislation in 2024, joining the ranks of 13 […]

Louis Lehot Offers Insight on Corporate M&A Momentum for 2024

Foley & Lardner LLP partner Louis Lehot is quoted in the Middle Market Growth article, “Corporate M&A Stirs up Momentum for 2024,” offering insight on the prospect of a resurgence in M&A activity this year. Dealmaking last year was muted across all industries, for strategics and private equity acquirers alike. But emerging data suggests an uptick for […]

Startup Advisors: What is vesting and why is it important?

Foley’s Startup Advisors answer questions that entrepreneurs need to know for their startup venture. We will be addressing questions startups regularly face – including entity formation, intellectual property protection, financing, and much more. In this video we discuss vesting and why it is important.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.